KOL KNOCKOUTTM: Medical Retina Edition

KOL KNOCKOUT Medical Retina Edition Competing for the Best Outcomes in Retina Round 1

The live program has concluded.

If you attended, please click on the "Take Post-Test" button to claim your credit. If you did not attend, please stay tuned for the archived version, which will be available soon for on-demand viewing.

Scroll back to top

Details

Overview
This popular CME program is a fun and exciting game show-style quiz competition that features key opinion leaders (KOLs) as contestants.
Hosted by Program Chair Sunil K. Srivastava, MD, the first of two rounds will feature Sruthi Arepalli, MD; Durga Borkar, MD, MMCi; and Ananth Sastry, MD. The KOLs will weigh in on their preferred treatment approach to various challenging case studies presented by Dr. Srivastava. The winner of Round 1 advances to the next round.
There will be learning, laughter, and only one KOL left standing!
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
Learning Objectives
Upon completion of this activity, the participant should be able to:
- Evaluate evidence-based management strategies for neovascular age-related macular degeneration
- Evaluate evidence-based management strategies for diabetic retinopathy/diabetic macular edema
- Evaluate evidence-based management strategies for retinal vein occlusion
- Examine the role of different imaging modalities in enhancing diagnostic precision and treatment planning for complex retinal pathologies
Accreditation
Provided by Evolve Medical Education
Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Evolve designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Participation Method
In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 11 for Windows
Edge (recent versions; Chromium-based) for Windows
Google Chrome (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Mozilla Firefox (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Safari (recent versions) for Mac OSX, or iOS
Hardware Requirements:
4GB+ RAM
Recommended internet speed 5Mbps+
Faculty and Disclosures
Sunil K. Srivastava, MD
Surgical Retina Fellowship Director
Cleveland Clinic Cole Eye Institute
Cleveland, OH

Sruthi Arepalli, MD
Assistant Professor
Vitreoretinal Surgery and Uveitis
Emory Eye Center
Atlanta, GA

Durga Borkar, MD, MMCi
Associate Professor of Ophthalmology
Associate Professor in Population Health Sciences
Director of Clinical Data Science
Duke University Eye Center
Durham, NC

Ananth Sastry, MD
Cleveland Clinic Cole Eye Institute
Cleveland, OH

DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.
The following faculty/staff members have the following financial relationships with ineligible companies.
Sunil K. Srivastava, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Adverum Biotechnologies, Bausch + Lomb, Carl Zeiss Meditec, EyePoint Pharmaceuticals, jCyte, and Regeneron. Grant/Research Support: Alimera Sciences, EyePoint Pharmaceuticals, and Regeneron.
Sruthi Arepalli, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: AbbVie and Alimera Sciences.
Durga Borkar, MD, MMCi, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alimera Sciences, Apellis Pharmaceuticals, Astellas, EyePoint Pharmaceuticals, Genentech, Glaukos, ONL Therapeutics, and Regeneron.
Ananth Sastry, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Apellis, Bausch + Lomb, and Dutch Ophthalmic Research Center.
The Evolve staff, planners and peer reviewer have no financial relationships with ineligible companies.
Disclaimer
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Regeneron Pharmaceuticals, Inc.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
  Apple Safari for Mac OS and iOS
  Mozilla Firefox for Windows, Mac OS, iOS, and Android
  Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Expiration Date: 11/28/2024

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Title

Share on ReachMD